CommercialCoverageLow impact
Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy
Blue Cross & Blue Shield of Mississippi·MS · Dermatology·Medical Policy
Effective date
Aug 1, 2025
We identified it
Jun 20, 2026
Summary
This Blue Cross Blue Shield of Mississippi policy confirms that dermatoscopy and computer-based optical imaging devices (like MelaFind) for evaluating skin lesions remain investigational and are not covered. No changes were made in the most recent review dated August 1, 2025.
Action Required
No immediate action required. This is a routine policy review with no changes. Continue to treat dermatoscopy and computer-based optical skin imaging devices as investigational/non-covered services for BCBS Mississippi members.